Medications for best results after MIGS

Comparison of post-operative cycloplegia, miotics, and no treatment after Minimally Invasive Glaucoma Surgery: A Randomized Controlled Trial. - Post MIGS meds

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/102925

Enrollment

Registered

2026-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa Health Condition 2: H409- Unspecified glaucoma

Interventions

Intervention1: MIGS: Minimally invasive glaucoam skurgery Control Intervention1: Atropine : Post op after MIGS surgery Control Intervention2: Pilocarpine: PAS after MIGS surgery Control Intervention3:

Eligibility

Inclusion criteria

Inclusion criteria: Any diagnosed case of glaucoma, undergoing MIGS during the study period.

Exclusion criteria

Exclusion criteria: Any patient with blood dyscrasia

Design outcomes

Primary

Measure	Time frame
The change of PAS from baseline The extent of PAS (in clock hours) IOP and correlation to PAS Timepoint: Three months	—

Secondary

Measure	Time frame
Intraocular PressureTimepoint: 3 months;Reduction in antiglaucoma medsTimepoint: 3 months	—

Countries

India

Contacts

Public ContactSushmita Kaushik

Post Graduate Institute of Medical Education and Research, Chandigarh

sushmita_kaushik@yahoo.com9814813207

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026